You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclin-dependent kinase 4/6 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Hospitalet de Llobregat, Barcelona, Spain
    • +6 more
    Jan 23, 2023

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

      Recruiting
      • Breast Cancer
      • CT scans
      • DEXA scan
      • Bronx, New York
        Montefiore Medical Center
      Jan 6, 2023

      Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

      Active, not recruiting
      Has Results
      • Advanced Breast Cancer
      • Beijing, Beijing, China
      • +6 more
      Jun 23, 2022

      Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

      Recruiting
      • Breast Cancer
      • Endocrine Therapy and a CDK 4/6 inhibitor
      • Baltimore, Maryland
        Johns Hopkins University
      Jul 18, 2022

      Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

      Recruiting
      • Recurrent Endometrial Carcinoma
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Oct 28, 2021

      Skin Health and Quality of Life in Patients Receiving

      Not yet recruiting
      • Lung Cancer
      • +7 more
      • EQ-5D-5L questionnaire
      • +2 more
      • Roma, Italy
        Roberto Iacovelli
      May 17, 2023

      Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

      Recruiting
      • Breast Cancer Stage IV
      • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
      • Mansoura, Dakahlia, Egypt
        Oncology center mansoura university
      Jan 1, 2023

      Cancer Trial in Boston (CYC065)

      Active, not recruiting
      • Cancer
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Apr 22, 2022

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • CDK Inhibitor AT7519
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Oct 18, 2022

      Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +4 more
      • CDK 4/6 inhibitors
      • Endocrine therapy
      • Helsinki, Finland
      • +11 more
      Sep 19, 2023

      Breast Cancer Trial (Chidamide+ Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • Chidamide+ Fulvestrant
      • (no location specified)
      Jan 13, 2022

      Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

      Not yet recruiting
      • Solid Tumors
      • (no location specified)
      May 17, 2023

      Oligodendroglioma, Oligoastrocytoma Trial in Spain (Palbociclib)

      Completed
      • Oligodendroglioma
      • Oligoastrocytoma
      • Las Palmas de Gran Canaria, Las Palmas, Spain
      • +10 more
      Apr 1, 2020

      Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

      Not yet recruiting
      • Breast Cancer
      • +5 more
      • (no location specified)
      Sep 9, 2022

      Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

      Completed
      Has Results
      • Breast Cancer
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 13, 2022

      Tumors, Breast Tumors Trial in Japan (PD-0332991, letrozole)

      Completed
      Has Results
      • Neoplasms
      • Breast Neoplasms
      • Nagoya, Aichi, Japan
      • +15 more
      Oct 28, 2020

      CDKL5 Deficiency Disorder Trial (Ganaxolone, Placebo)

      Not yet recruiting
      • CDKL5 Deficiency Disorder
      • (no location specified)
      Feb 18, 2022

      Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

      Completed
      Has Results
      • Adult Solid Tumor
      • +38 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of The University of Pennsylvania
      Feb 18, 2021

      Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Breast Carcinoma
      • Birmingham, Alabama
      • +12 more
      Feb 17, 2022